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CASE REPORT
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Sturge-Weber syndrome (SWS) is a neurocutaneous syn-
drome, characterized by the association of facial port-wine 
hemangiomas in the trigeminal nerve distribution area, with 
vascular malformation(s) of the brain (leptomeningeal 
angioma) with or without glaucoma. Herein, we reported 
Sturge-Weber syndrome in a 50-year-old man, who pre-
sented port-wine hemangiomas and epilepsy. In this case, 
the patient’s epilepsy episodes from his first year of life had 
been ignored and separated from the entity of SWS by his 
physicians, which led to delayed treatment. This case 
illustrates the importance of careful examination of patients 
of any age with hemangiomas in the trigeminal nerve with 
concomitant episodes of epilepsy. In such cases, there 
should be yearly neuroimaging screenings to guaranteed 
early interdisciplinary interventions from the time of definite 
diagnosis. (Ann Dermatol 23(4) 551∼553, 2011)
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INTRODUCTION
Sturge-Weber syndrome (SWS, also called encephalofacial 
or encephalotrigeminal angiomatosis) is a neurocutaneous 
syndrome, characterized by the association of facial 
port-wine hemangiomas in the trigeminal nerve distri-
bution area, with a vascular malformation of the brain 
(leptomeningeal angioma) with or without glaucoma
1. 
Although facial hemangiomas in SWS are typical at birth, 
they are prone to misdiagnosis as haplo-hemangiomas, if 
other concomitant symptoms are not considered together, 
which may lead to delayed diagnosis and intervention.
CASE REPORT
This 50-year-old man was admitted to Daping Hospital for 
evaluation and aesthetic treatment of left facial port-wine 
nodules, which presented as port-wine stains at birth. 
With his increasing age, the stains darkened in color and 
became raised and thickened. His family complained of 
his episodes of epilepsy, which  started during the first 
year of his life. He had been taking phenobarbital to 
control the epilepsy; however,  the epilepsy became more 
intense. 
On examination, well-demarcated cutaneous port-wine 
macular stains and vascular nodules were observed on the 
left side of the face that followed the trigeminal nerve 
distribution area (Fig. 1A). Hemiatrophy of his right leg 
and failure of closing together of the right fingers were 
observed. There was no evidence for either contralateral 
hemiplegia or intellectual disability. A skin biopsy from 
one of the angiomatous nodules showed a cavernous 
hemangioma pattern, and dilated and ectatic thin-walled 
vessels in the superficial dermis were observed. 
Immunohistochemistry results (immunoperoxidase method) 
showed CD34(＋), CD31(＋), and Ki67(−) (Fig. 2). There 
were no abnormalities related to his right eye, and his left 
visual field was blocked by the port-wine nodules. 
Radiologically, homolateral cerebral atrophy and subcor-
tical calcifications in the left occipital lobe and leptome-
ningeal vascular angiomas located in the parietooccipital 
area were indicated on computed tomographic (CT) scans, 
magnetic resonance imaging (MRI), and cerebral CT 
angiography, respectively (Fig. 1B, C). The diagnosis of L Chen, et al
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Fig. 1. Clinical photograph (panel 
A) and patient computed tomography
and CDA radiological data (panel B 
and C).
SWS was made according to the clinical and neuroi-
maging characteristics. His left superficial temporal artery 
was ligated and the port-wine nodules were excised by 
neurologic surgeons. Subsequently, his episodes of epilep-
sy ceased.
DISCUSSION
The incidence of SWS is three percent in patients with a 
facial port-wine hemangioma
2. There is an increased risk 
of SWS with involvement of the ophthalmic division of the 
trigeminal nerve. Facial port-wine hemangiomas, whether 
or not associated with SWS, usually have a sharp midline 
demarcation, although some extension over the midline 
has been observed
3.
Computed tomography angiography, MRI, and CT are the 
best modalities to demonstrate the vascular malformation, 
the impaired cerebral venous drainage, and the atrophy of 
one hemisphere and calcifications, respectively. Atrophy 
and calcifications are considered to be an indirect conse-
quence of chronic ischemia of the cortex due to vascular 
stasis in the area of leptomeningeal angioma. Recent ad-
vances in neuroimaging have provided important insights 
into the progression of neurologic injury that occurs as a 
result of impaired blood flow. Important limitations exist, 
however, as currently the early diagnosis and exclusion of 
SWS is impaired by the poor sensitivity of imaging in the 
newborn period and early infancy
1. Epilepsy, hemiparesis, 
mental retardation, and ocular problems were the most 
frequent and severe features of patients with SWS. Limited 
intelligence and social skills, poor aesthetic appearance, 
and epilepsy complicate the integration of the patients. 
The clinical severity of this case is not the originality of 
our paper, because no relationship was observed between 
the size of the facial port-wine hemangiomas and the se-
verity of the brain lesion
4,5. Symptoms depend upon the 
extent and location of the venous dysplasia. Early onset of 
epilepsy and poor response to medical treatment, bilateral 
cerebral involvement, and unilateral severe lesions are in-
dicative of a poor prognosis
4. Early surgery is more likely 
to improve developmental outcome, although, in some in-
stances, therapies aimed at obliterating port-wine he-
mangiomas to minimize cosmetic blemishes may worsen 
blood stasis within the brain and potentially exacerbate 
neurologic symptoms
6,7. Considering the complications 
that may be emerged during the treatment, especially the 
patient’s own possible apprehension of the condition, it is 
imperative that the diagnostician and surgeon have thor-
ough knowledge of this syndrome.
In this case, the episodes of epilepsy from birth had been 
ignored and separated from SWS by his physicians, which 
led to delayed treatments for nearly 50 years. As we said 
above, the clinical severity does not represent the origi-
nality of this case. Rather, this case illustrates the im-
portance of careful examination of patients of any age 
with hemangiomas in the trigeminal nerve with con-
comitant episodes of epilepsy. Such patients require  year-
ly neuroimaging examinations. Thorough knowledge of Sturge-Weber Syndrome
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Fig. 2. Skin biopsy from one of the angiomatous nodules showed a cavernous hemangioma pattern. Dilated and ectatic thin-walled 
vessels in the superficial dermis were observed (panel A). Immunohistochemistry results (immunoperoxidase method) showed CD34(＋),
CD31(＋), and Ki67(−) (panels B, C, and D).
this syndrome and high awareness of this entity may lead 
to earlier diagnosis and more timely and appropriate med-
ical interventions.
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